Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion type Assertion NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_head.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion description "[Olaparib has antitumor activity in BRCA1/2 mutation ovarian cancer, which is associated with platinum sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_provenance.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion evidence source_evidence_literature NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_provenance.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion SIO_000772 20406929 NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_provenance.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion wasDerivedFrom befree-2016 NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_provenance.
- NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_assertion wasGeneratedBy ECO_0000203 NP807208.RAXgul899_3zefoNgnviiSTt7ZkrM_A8a98USOEGYR1FU130_provenance.